
-
Mind Medicine (MindMed) Inc. NASDAQ:MNMD Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.
Location: One World Trade Center, Suite 8500, New York, V6E 3Z3, United States | Website: https://mindmed.co/ | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
288.5M
Cash
295.3M
Avg Qtr Burn
-18.59M
Short % of Float
15.04%
Insider Ownership
0.72%
Institutional Own.
57.20%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MM120 (lysergide D-tartrate) Details Major depressive disorder | Phase 3 Data readout | |
MM120 (lysergide D-tartrate) Details Anxiety Disorders | Phase 3 Data readout | |
MM402 (R(-)-MDMA) Details Autism spectrum disorders | Phase 1 Update |